Labilact vaginal capsules №10

Description

Labilact Composition
1 capsule contains: live lyophilized bacteria Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium bifidum, Bifidobacterium adolescerrtis -109 CFU / g; lactulose – 20 mg.

Labilact Properties
Lactobacilli are one of the dominant microorganisms of the normal microflora of the female genital tract; they perform a protective function in the vagina. Fermented glycogen of the vaginal epithelium, lactobacilli form a number of organic acids, due to which low pH values ​​of the vagina are maintained, the production of hydrogen peroxide by lactobacilli is one of the most important defense mechanisms, creates unfavorable conditions for the colonization and development of pathogenic microorganisms. Bifidobacteria are fixed on the surface of the vaginal epithelial cells. They are also acid-producing microorganisms and are involved in maintaining a low pH. In addition, bifidobacteria produce bacteriocins, lysozyme, alcohols, are factors of colonization resistance in the vagina against pathogenic and opportunistic microorganisms.

Lactulose is a selective nutrient medium for the introduced bacteria. Its presence in Labilact® enables the development of beneficial bacteria even in the absence of endogenous glycogen. The products of the bacterial metabolism of lactulose (short-chain fatty acids) also lower the pH of the vaginal contents.

Labilact Recommendations for use
Labilact® is recommended for use for:

updating the composition of the normal flora after local and systemic use of antibiotics, antimicrobial, antifungal and non-steroidal anti-inflammatory drugs against sexually transmitted diseases, inflammatory diseases of the female genital area;
prevention of diseases of the female genitalia, accompanied by violations of the normal microflora (candidiasis, gardnerellosis);
correction of vaginal dysbiosis (candidiasis, gardnerellosis);
normalization of the composition of the vaginal microflora of a pregnant woman during her preparation for childbirth;
reduction of clinical symptoms (itching, burning, discomfort) during the systemic use of antibiotics, antimicrobial, antifungal and non-steroidal anti-inflammatory drugs against sexually transmitted diseases, inflammatory diseases of the female genital area;
updating the composition of the vaginal microflora in adolescence;
reducing the frequency of recurrences of inflammatory diseases of the female genital area;
prevention and use in the complex of treatment of climacteric syndrome.

Mode of application

Labilact® is used intravaginally. Pre-moisten the vaginal capsule with boiled water, then insert it deeply into the vagina. It is better to do this while lying on your back with your knees slightly bent.

Course of application: 1 vaginal capsule 1 time per day for 10 days.
It is not recommended to exceed the indicated dosage amount.
Labilact® contains components that may not completely degrade; capsule remnants can sometimes be found on underwear. This does not affect the effectiveness of the product.

Contraindications
Hypersensitivity to the components of the product.

Storage conditions
Store in a dry, dark place and out of reach of children
at temperatures from 0 ° С to + 25 ° С and relative humidity no more than 75%.

Release form
Vaginal capsules, 10 capsules in a blister.

Shelf life
12 months from the date of manufacture.